Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease

Condition:   Idiopathic Parkinson's Disease Intervention:   Biological: Aadipose-Derived Mesenchymal Stem Cells Sponsor:   Taiwan Mitochondrion Applied Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials